We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+17.9%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12.6B
AUM Growth
+$1.99B
Cap. Flow
-$290M
Cap. Flow %
-2.3%
Top 10 Hldgs %
21.14%
Holding
876
New
80
Increased
408
Reduced
263
Closed
68

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$146M
2
CRM icon
Salesforce
CRM
+$65.4M
3
MRK icon
Merck
MRK
+$57.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$50.8M
5
C icon
Citigroup
C
+$46.5M

Sector Composition

Rank Sector Weight
1 Healthcare 34.01%
2 Technology 22.68%
3 Consumer Discretionary 9.38%
4 Financials 7.85%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIDU icon
101
Baidu
BIDU
$35.6B
$32.3M 0.26%
149,472
+21,160
+16% +$3.14M
T icon
102
AT&T
T
$169B
$32.2M 0.25%
1,482,436
+207,873
+16% +$4.48M
APLS
103
DELISTED
Apellis Pharmaceuticals
APLS
$31.8M 0.25%
555,374
-593,491
-52% -$25.1M
BMRN icon
104
BioMarin Pharmaceuticals
BMRN
$12B
$31.4M 0.25%
358,030
-9,789
-3% -$776K
HALO icon
105
Halozyme
HALO
$9.9B
$31.3M 0.25%
733,754
-312,718
-30% -$11.2M
ECL icon
106
Ecolab
ECL
$79.6B
$31.1M 0.25%
143,870
+26,408
+22% +$5.52M
DRNA
107
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$31M 0.25%
1,408,993
+199,787
+17% +$4.4M
KURA icon
108
Kura Oncology
KURA
$826M
$30.4M 0.24%
929,282
+390,086
+72% +$13.7M
VMW
109
DELISTED
VMware, Inc
VMW
$30.2M 0.24%
215,461
-19,454
-8% -$2.79M
MRSN
110
DELISTED
Mersana Therapeutics
MRSN
$29.9M 0.24%
44,886
+21,378
+91% +$11.9M
INTU icon
111
Intuit
INTU
$85.6B
$29.8M 0.24%
78,478
+17,248
+28% +$6.06M
BILI icon
112
Bilibili
BILI
$7.56B
$29.3M 0.23%
341,998
+88,898
+35% +$5.21M
BAC icon
113
Bank of America
BAC
$439B
$28.8M 0.23%
950,336
+72,896
+8% +$1.95M
TXN icon
114
Texas Instruments
TXN
$253B
$28.6M 0.23%
174,013
-39,643
-19% -$6.16M
ENPH icon
115
Enphase Energy
ENPH
$4.79B
$28.5M 0.23%
162,286
+4,341
+3% +$551K
SLAB icon
116
Silicon Laboratories
SLAB
$7.17B
$28.4M 0.22%
222,686
+53,719
+32% +$6.05M
EBAY icon
117
eBay
EBAY
$52.1B
$28.3M 0.22%
563,059
+279,001
+98% +$14.2M
SEDG icon
118
SolarEdge
SEDG
$2.44B
$28.1M 0.22%
88,195
-9,113
-9% -$2.52M
SRPT icon
119
Sarepta Therapeutics
SRPT
$1.63B
$28M 0.22%
164,008
-10,821
-6% -$1.6M
WMS icon
120
Advanced Drainage Systems
WMS
$11.1B
$27.9M 0.22%
333,395
+51,046
+18% +$3.62M
TIF
121
DELISTED
Tiffany & Co.
TIF
$27.7M 0.22%
211,070
+16,606
+9% +$2.13M
IOVA icon
122
Iovance Biotherapeutics
IOVA
$2.1B
$27.5M 0.22%
592,062
-93,019
-14% -$3.69M
HRTX icon
123
Heron Therapeutics
HRTX
$92M
$27.3M 0.22%
1,289,773
-29,199
-2% -$507K
QRVO icon
124
Qorvo
QRVO
$8.09B
$27.1M 0.21%
163,099
+46,150
+39% +$6.79M
LBRDK icon
125
Liberty Broadband Class C
LBRDK
$4.72B
$26.5M 0.21%
167,543
+161,898
+2,868% +$24.6M

Similar funds

Candriam SCA's Q4 2020 Portfolio in Review

As of Q4 2020, Candriam SCA held 876 positions worth $12.6B, up 19% from $10.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q4 2020 filing shows 80 new, 408 increased, 263 reduced and 68 closed positions. Its largest new stake was Salesforce: 269,070 shares worth $59.9M. The largest sale was Amazon, an estimated $76.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q4 2020 buy was Salesforce: 269,070 shares worth $59.9M.
  • Candriam SCA added most to Apple in Q4 2020, an estimated $146M increase.
  • Candriam SCA's biggest Q4 2020 reduction was Amazon, cutting an estimated $76.3M.
  • Candriam SCA fully exited VIVINT SOLAR, INC. in Q4 2020, selling an estimated $35.6M.
  • Candriam SCA's ten largest holdings make up 21% of its $12.6B portfolio in Q4 2020.
  • Candriam SCA opened 80 new positions and closed 68 in Q4 2020.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $12.6B.

Based on Candriam SCA's 13F filing for Q4 2020, filed 22 Jan 2021.